Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD)

ClinicalTrials.gov ID: NCT00104273

Public ClinicalTrials.gov record NCT00104273. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 12:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 1-Year, Double-Blind, Randomized, Placebo-Controlled, Study of Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Dementia of the Alzheimer's Type

Study identification

NCT ID
NCT00104273
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Industry
Enrollment
376 participants

Conditions and interventions

Interventions

  • Rasagiline Drug

Drug

Eligibility (public fields only)

Age range
45 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2004
Primary completion
Feb 28, 2007
Completion
Not listed
Last update posted
Jul 14, 2009

Started 2004

United States locations

U.S. sites
31
U.S. states
21
U.S. cities
27
Facility City State ZIP Site status
Collaborative Neuroscience Network Huntsville Alabama 35801
North Alabama Neuroscience Research Huntsville Alabama 35801
Northwest Neurospecialists, PLLC Tucson Arizona 85741-3537
Clinical Study Centers, LLC Little Rock Arkansas 72205
East Bay Region Associates in Neurology Berkeley California 94705
Margolin Brain Institute Fresno California 93720
Collaborative Neuroscience Network Garden Grove California 92845
San Francisco Clinical Research Center San Francisco California 94109
Neurological Research Institute Santa Monica California 90404
University of Colorado Health Sciences Center Denver Colorado 80262
Premiere Research Institute West Palm Beach Florida 33407
North Broward Medical Center/Memory Disorder Center West Palm Beach Florida 33409
Emory University Wesley Woods Health Center Altanta Georgia 30329
Dekalb Neurology Associates, LLC Decatur Georgia 30033
Radiant Research Chicago Illinois 60610
Fort Wayne Neurological Center Fort Wayne Indiana 46805
Mid America Neuroscience Institute Lenexa Kansas 66214
Four Rivers Clinical Research Paducah Kentucky 42003
Tulane University Health Sciences Center, Dept of Psychiatry and Neurology New Orleans Louisiana 70112
Department of Neurology - Brigham and Women's Hospital Boston Massachusetts 02115
Northern Michigan Neurology Traverse City Michigan 49684
University Behavioral Healthcare Centre Department of Psychiatry Piscataway New Jersey 08854
Odyssey Research Fargo North Dakota 58104
Ohio State University, Department of Neurology Columbus Ohio 43210
Pahl Brain Associates Oklahoma City Oklahoma 73118
Medical University of South Carolina Alzheimer's Research and Clinical Programs North Charleston South Carolina 29406-6076
Department of Neurology Baylor College of Medicine Houston Texas 77030-2744
Premiere Research Institute Houston Texas 77030
University of Texas Mental Sciences Institute Houston Texas 77030
Peninsula Internal Medicine Associates Gig Harbor Washington 98335
Internal Medicine Northwest Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00104273, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 14, 2009 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00104273 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →